← Zepp Health Corp ZEPP
Market Price
$5.49
Market Cap
$79.92M
P/E Ratio
N/A
Revenue (FY 2025)
↑41.8% YoY
$258.90M
3-Yr CAGR: -24.5%
Net Income
↑47.1% YoY
-$40.07M
Net Margin: -15.5%
Free Cash Flow
↓-1.6% YoY
-$26.21M
FCF Yield: -32.79%
EPS (Diluted)
↑44.8% YoY
$-0.16
Basic: $-0.16
Return on Equity
Efficiency
-18.7%
ROA: -7.1%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (ZEPP)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $1,556.5M | — | $276.2M | $23.9M | — | $-0.22 | — | $17.3M | $7.0M | — |
| FY 2017 | $314.9M | -79.8% | $76.0M | $25.8M | +7.6% | $0.10 | +145.5% | $36.6M | $33.3M | +376.8% |
| FY 2018 | $530.2M | +68.4% | $136.6M | $49.5M | +91.9% | $0.07 | -30.0% | $102.9M | $100.4M | +201.3% |
| FY 2019 | $834.9M | +57.5% | $210.8M | $82.6M | +67.1% | $0.32 | +357.1% | $61.5M | $56.6M | -43.7% |
| FY 2020 | $986.0M | +18.1% | $204.2M | $35.1M | -57.6% | $0.13 | -59.4% | $24.1M | $11.3M | -80.0% |
| FY 2021 | $980.8M | -0.5% | $204.9M | $21.6M | -38.3% | $0.08 | -38.5% | $-36.5M | $-43.7M | -486.7% |
| FY 2022 | $600.7M | -38.8% | $116.4M | $-41.8M | -293.3% | $-0.17 | -312.5% | $-114.2M | $-115.4M | -164.0% |
| FY 2023 | $351.5M | -41.5% | $92.6M | $-29.9M | +28.5% | $-0.12 | +29.4% | $42.1M | $40.5M | +135.1% |
| FY 2024 | $182.6M | -48.0% | $70.2M | $-75.7M | -153.5% | $-0.29 | -141.7% | $-24.4M | $-25.8M | -163.7% |
| FY 2025 | $258.9M | +41.8% | $99.2M | $-40.1M | +47.1% | $-0.16 | +44.8% | $-25.7M | $-26.2M | -1.6% |
Valuation
Market Price
$5.49
Market Cap
$79.92M
Enterprise Value
$82.35M
P/E Ratio
N/A
P/B Ratio
0.37
FCF Yield
-32.79%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
38.31%
Operating Margin
-11.29%
Net Margin
-15.48%
Return on Equity (ROE)
-18.68%
Return on Assets (ROA)
-7.09%
Asset Turnover
0.46x
Revenue 3-Yr CAGR
-24.46%
Financial Health & Liquidity
Current Ratio
45.26
Cash Ratio
75.36
Debt / Equity
0.277
Debt / Assets
0.105
Cash & Equivalents
$57.05M
Total Debt
$59.48M
Book Value / Share
$14.63
Cash Flow Efficiency
Operating Cash Flow
-$25.69M
Capital Expenditures (CapEx)
$516.00K
Free Cash Flow
-$26.21M
OCF / Revenue
-9.92%
FCF / Revenue
-10.12%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-0.16
EPS (Basic)
$-0.16
Dividends / Share
N/A
Book Value / Share
$14.63
EPS YoY Growth
44.83%
Balance Sheet (FY 2025)
Total Assets
$564.84M
Total Liabilities
$350.30M
Stockholders' Equity
$214.53M
Current Assets
$34.26M
Current Liabilities
$757.00K